Accessibility Menu
 
Arrow-Thin-Down
S&P 500
6,582.69
+0.1%
+7.37
Arrow-Thin-Down
DJI
46,504.67
-0.1%
-61.07
Arrow-Thin-Down
NASDAQ
21,879.18
+0.2%
+38.23
Arrow-Thin-Down
Bitcoin
$67,619.00
+0.5%
+$350.57
Arrow-Thin-Down
AMZN
$209.70
-0.4%
-$0.87
Arrow-Thin-Down
GOOG
$294.46
-0.1%
-$0.44
Arrow-Thin-Down
META
$574.46
-0.8%
-$4.77
Arrow-Thin-Down
MSFT
$373.10
+1.0%
+$3.73
Arrow-Thin-Down
NVDA
$177.39
+0.9%
+$1.64
Arrow-Thin-Down
TSLA
$360.45
-5.5%
-$20.81
Most Active StocksDaily Stock GainersDaily Stock Losers
Nathaniel Calloway

Nathaniel Calloway

ntcalloway
Nathaniel Calloway is a biomedical scientist and fool since 2014. He focuses on the pharmaceutical industry across all market caps, with a special focus on clinical leads and regulatory impact.

Articles by Nathaniel Calloway — Page 3

No articles found on this page.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services